Literature DB >> 22483586

Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor.

Shang-Ke Chen1, Peng Zhao, Yong-Xian Shao, Zhe Li, Cuixian Zhang, Peiqing Liu, Xixin He, Hai-Bin Luo, Xiaopeng Hu.   

Abstract

Phosphodiesterase-4 (PDE4) has been identified to be a promising target for treatment of asthma. Moracin M extracted from Chinese herbal drug 'Sang-Bai-Pi' (Morus alba L.) was studied for the inhibitory affinity towards PDE4. It inhibited PDE4D2, PDE4B2, PDE5A1, and PDE9A2 with the IC(50) values of 2.9, 4.5, >40, and >100 μM, respectively. Our molecular docking and 8ns molecular dynamics (MD) simulations demonstrated that moracin M forms three hydrogen bonds with Gln369, Asn321, and Asp318 in the active site and stacks against Phe372. In addition, comparative kinetics analysis of its analog moracin C was carried out to qualitatively validate their inhibitory potency as predicted by the binding free energy calculations after MD simulations.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483586     DOI: 10.1016/j.bmcl.2012.03.026

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.

Authors:  Minghao Zheng; Zhihong Liu; Xin Yan; Qianzhi Ding; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-09-03       Impact factor: 2.943

2.  The COPD Pipeline XXXI.

Authors:  Nicholas Gross
Journal:  Chronic Obstr Pulm Dis       Date:  2016-04-18

Review 3.  Use of Natural Products in Asthma Treatment.

Authors:  Lucas Amaral-Machado; Wógenes N Oliveira; Susiane S Moreira-Oliveira; Daniel T Pereira; Éverton N Alencar; Nicolas Tsapis; Eryvaldo Sócrates T Egito
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-13       Impact factor: 2.629

4.  Six new tetraprenylated alkaloids from the South China Sea gorgonian Echinogorgia pseudossapo.

Authors:  Zhang-Hua Sun; Ying-Hong Cai; Cheng-Qi Fan; Gui-Hua Tang; Hai-Bin Luo; Sheng Yin
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.